Situaciones de broncoespasmo, obstrucción de las vías aéreas superiores, hipersecreción bronquial y determinadas características de los circuitos externos del. Contraindicada en casos de hipersensibilidad a la levodropropizina o compuestos estructuralmente relacionados, hipersecreción bronquial o función. Se asocia a: Hiperreactividad bronquial con episodios recurrentes de sibilancias, disnea, opresión torácica y tos. Obstrucción bronquial difusa.
|Published (Last):||21 September 2009|
|PDF File Size:||3.87 Mb|
|ePub File Size:||2.83 Mb|
|Price:||Free* [*Free Regsitration Required]|
Asma Bronquial by Marlon Leonel on Prezi
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction. Steinfort DP, Steinfort C. Remote access to EBSCO’s databases is permitted to patrons of subscribing institutions accessing from hipersecrecino locations for personal, non-commercial use.
Pisi G, Chetta A.
Monografías de Archivos de Bronconeumología
A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas. UK Cystic Fibrosis Trust.
Criteria for the assessment of reversibility in airways obstruction. Comparison bronquoal bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis–a randomised hipersecreicon trial. Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. An elevated bronchodilator response predicts large airway inflammation in mild asthma.
Lung volumes and forced ventilatory flows. Nebulized amoxicillin in chronic hipersecrecon bronchiectasis. Repeatibility of spirometry in 18, adult patients. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis. No adverse events were reported with acebrophylline. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.
British Thoracic Society guideline for non-CF bronchiectasis. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Airway clearance hipersecrecioon in cystic fibrosis patients.
Am Rev Respir Dis. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis. Brain B, et al. Response to isoproterenol in a general population sample. Global Strategy for Asthma Management and Prevention. A pilot study of the safety and bronqiual of tobramycin solution for inhalation in patients with severe bronchiectasis.
Asma Bronquial by Camila Tiznado on Prezi
Exercise training and inspiratory muscle training in patients with bronchiectasis. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
However, remote access to EBSCO’s databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient.
Randomized, controlled, double blind, parallel, prospective design with rescue medication. Improved criterion for assessing lung function reversibility. Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa. Similarly, there was no-significant increase in FAV1 in the acebrophylline group and a slight decrease in the placebo group. J Allergy Clin Immunol. An evaluation of test used to measure bronchodilator response.
Long-term treatment of bronchiectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycin-penicillin mixture.
Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non cystic fibrosis bronchiectasis: Inhaled mannitol for non-cystic fibrosis bronchiectasis: Cochrane Database Syst Rev.
The disease-modifying effects of twiceweekly oral azithromycin in patients with bronchiectasis. Clinical interpretation of airway response to a bronchodilator: Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.
Worldwide patterns of bronchodilator responsiveness: Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy.
The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry? Effect of roxithromycin on airway responsiveness in children with bronchiectasis: